Kidney and preeclampsia;Rein et prééclampsie

Annales Francaises d'Anesthesie et de Reanimation

Volumn 29, Issue 4, 2010, Pages

  Moulin, B ^a   Hertig, A ^b   Rondeau, E ^b  

^a HÔPITAL CIVIL   (France)

^b HÔPITAL TENON   (France)

Author keywords

Acute renal failure; Hypertension; Preeclampsia; Pregnancy

Indexed keywords

DOPAMINE; FUROSEMIDE; SODIUM;

ACUTE KIDNEY FAILURE; ACUTE KIDNEY TUBULE NECROSIS; ARTICLE; BLOOD PRESSURE; DIALYSIS; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DISEASE SEVERITY; ENDOTHELIUM; ESSENTIAL HYPERTENSION; GLOMERULUS FILTRATION RATE; HEMOLYTIC UREMIC SYNDROME; HISTOPATHOLOGY; HUMAN; HYPERURICEMIA; INFECTION; INFLAMMATION; KIDNEY BLOOD FLOW; KIDNEY DISEASE; LUNG EDEMA; MORTALITY; OLIGURIA; PATHOPHYSIOLOGY; PREECLAMPSIA; PROGNOSIS; PROTEINURIA; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SODIUM BALANCE; THIRD TRIMESTER PREGNANCY; VASCULAR RESISTANCE; WATER RETENTION;

ADULT; DIURETICS; DOPAMINE; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY; MONITORING, PHYSIOLOGIC; PRE-ECLAMPSIA; PREGNANCY; RENAL CIRCULATION; RENAL INSUFFICIENCY;

EID: 77952876023     PISSN: 07507658     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.annfar.2010.02.022     Document Type: Article

References (41)

1. Baylis C., Davison J. Renal physiology in normal pregnancy. Comprehensive clinical nephrology 2007, 475-481. Mosby Elsevier, Philadelphia. 3rd ed. J. Feehaly, J. Floege, R. Johnson (Eds.).
2. Maynard S.E., Min J.Y., Merchan J., Lim K.H., Li J., Mondal S., et al. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest 2003, 111:649-658.
3. Luttun A., Carmeliet P. Soluble VEGF receptor Flt1: the elusive preeclampsia factor discovered?. J Clin Invest 2003, 111:600-602.
4. Eremina V., Sood M., Haigh J., Nagy A., Lajoie G., Ferrara N., et al. Glomerular-specific alterations of VEGF-A expression lead to distinct congenital and acquired renal diseases. J Clin Invest 2003, 111:707-716.
5. Sugimoto H., Hamano Y., Charytan D., Cosgrove D., Kieran M., Sudhakar A., et al. Neutralization of circulating vascular endothelial growth factor (VEGF) by anti-VEGF antibodies and soluble VEGF receptor 1 (sFlt-1) induces proteinuria. J Biol Chem 2003, 278:12605-12608.
6. Venkatesha S., Toporsian M., Lam C., Hanai J., Mammoto T., Kim Y.M., et al. Soluble endoglin contributes to the pathogenesis of preeclampsia. Nat Med 2006, 12:642-649.
7. Thangaratinam S., Ismail K., Sharp S., Coomarasamy A., O'Mahony F., Khan K.S., et al. Prioritisation of tests for the prediction of preeclampsia complications: a Delphi survey. Hypertens Pregnancy 2007, 26:131-138.
8. Naeye R.L., Friedman E.A. Causes of perinatal death associated with gestational hypertension and proteinuria. Am J Obstet Gynecol 1979, 133:8-10.
9. Sibai B.M., McCubbin J.H., Anderson G.D., Lipshitz J., Dilts P.V., Eclampsia I. Observations from 67 recent cases. Obstet Gynecol 1981, 58:609-613.
10. Vosburgh G.J. Blood pressure, edema and proteinuria in pregnancy. 5. Edema relationships. Prog Clin Biol Res 1976, 7:155-168.
11. Redman C.W., Beilin L.J., Bonnar J., Wilkinson R.H. Plasma-urate measurements in predicting fetal death in hypertensive pregnancy. Lancet 1976, 1:1370-1373.
12. Thangaratinam S., Ismail K.M., Sharp S., Coomarasamy A., Khan K.S. Accuracy of serum uric acid in predicting complications of pre-eclampsia: a systematic review. BJOG 2006, 113:369-378.
13. Merviel P., Ba R., Beaufils M., Breart G., Salat-Baroux J., Uzan S. Lone hyperuricemia during pregnancy: maternal and fetal outcomes. Eur J Obstet Gynecol Reprod Biol 1998, 77:145-150.
14. Paller M.S. Hypertension in pregnancy. J Am Soc Nephrol 1998, 9:314-321.
15. Diemunsch P., Langer B., Noll E. Principes généraux de la prise en charge hospitalière de la prééclampsie. Ann Fr Anesth Réanim 2010, 29:e51-e58.
16. Ihle B.U., Long P., Oats J. Early onset pre-eclampsia: recognition of underlying renal disease. Br Med J (Clin Res Ed) 1987, 294:79-81.
17. Jungers P., Houillier P., Forget D., Labrunie M., Skhiri H., Giatras I., et al. Influence of pregnancy on the course of primary chronic glomerulonephritis. Lancet 1995, 346:1122-1124.
18. Jungers P., Chauveau D., Choukroun G., Moynot A., Skhiri H., Houillier P., et al. Pregnancy in women with impaired renal function. Clin Nephrol 1997, 47:281-288.
19. Imbasciati E., Gregorini G., Cabiddu G., Gammaro L., Ambroso G., Del Giudice A., et al. Pregnancy in CKD stages 3 to 5: fetal and maternal outcomes. Am J Kidney Dis 2007, 49:753-762.
20. Fischer M.J., Lehnerz S.D., Hebert J.R., Parikh C.R. Kidney disease is an independent risk factor for adverse fetal and maternal outcomes in pregnancy. Am J Kidney Dis 2004, 43:415-423.
21. Gammill H.S., Jeyabalan A. Acute renal failure in pregnancy. Crit Care Med 2005, 33:S372-S384.
22. Bellomo R. Defining, quantifying, and classifying acute renal failure. Crit Care Clin 2005, 21:223-237.
23. Grunfeld J., Pertuiset N. Acute renal failure in pregnancy. Am J Kidney Dis 1987, 9:359-362.
24. Sibai B., Ramadan M. Acute renal failure in pregnancies complicated by hemolysis, elevated liver enzymes, and low platelets. Am J Obstet Gynecol 1993, 168(6Pt 1):1682-1687.
25. Cunningham F.G., Cox S.M., Harstad T.W., Mason R.A., Pritchard J.A. Chronic renal disease and pregnancy outcome. Am J Obstet Gynecol 1990, 163:453-459.
26. Castro M.A., Fassett M.J., Reynolds T.B., Shaw K.J., Goodwin T.M. Reversible peripartum liver failure: a new perspective on the diagnosis, treatment, and cause of acute fatty liver of pregnancy, based on consecutive cases. Am J Obstet Gynecol 1999, 181:389-395.
27. McCrae K., Cines D. Thrombotic microangiopathy during pregnancy. Sem Hematol 1997, 34:148-158.
28. Vesely S.K., Li X., McMinn J.R., Terrell D.R., George J.N. Pregnancy outcomes after recovery from thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Transfusion 2004, 44:1149-1158.
29. May H.J., Harbert G.J., Thornton W.J. Thrombotic thrombocytopenic purpura associated with pregnancy. Am J Obstet Gynecol 1976, 126:452-458.
30. Egerman R., Witlin A., Friedman S., Sibai B. Thrombotic thrombocytopenic purpura and hemolytic uremic syndrome in pregnancy: review of 11 cases [see comments]. Am J Obstet Gynecol 1996, 175(4Pt 1):950-956.
31. Lian E., Byrnes J., Harkness D. Two successful pregnancies in a woman with chronic thrombotic thrombocytopenic purpura treated by plasma infusion. Am J Hematol 1984, 16:287-291.
32. Moore J., Baldisseri M.R. Amniotic fluid embolism. Crit Care Med 2005, 33:S279-S285.
33. Black R. Vascular diseases of the kidney. Pathophysiology of renal disease 1987, 349-353. McGraw-Hill, New- York. 2nd ed. B. Rose (Ed.).
34. Matlin R., Gary N. Acute tubular necrosis: case report and review of literature. Am J Med 1974, 56:110.
35. Shultz P., Raij L. Endogenously synthesized nitric oxide prevents endotoxin-induced glomerular thrombosis. J Clin Invest 1992, 90:1718-1725.
36. Clark S.L., Greenspoon J.S., Aldahl D., Phelan J.P. Severe preeclampsia with persistent oliguria: management of hemodynamic subsets. Am J Obstet Gynecol 1986, 154:490-494.
37. Clark S.L., Cotton D.B. Clinical indications for pulmonary artery catheterization in the patient with severe preeclampsia. Am J Obstet Gynecol 1988, 158(3Pt 1):453-458.
38. Nolan T.E., Wakefield M.L., Devoe L.D. Invasive hemodynamic monitoring in obstetrics. A critical review of its indications, benefits, complications, and alternatives. Chest 1992, 101:1429-1433.
39. Kirshon B., Lee W., Mauer M.B., Cotton D.B. Effects of low-dose dopamine therapy in the oliguric patient with preeclampsia. Am J Obstet Gynecol 1988, 159:604-607.
40. Mantel G.D., Makin J.D. Low dose dopamine in postpartum pre-eclamptic women with oliguria: a double- blind, placebo controlled, randomised trial. Br J Obstet Gynaecol 1997, 104:1180-1183.
41. Ascarelli M.H., Johnson V., McCreary H., Cushman J., May W.L., Martin J.N. Postpartum preeclampsia management with furosemide: a randomized clinical trial. Obstet Gynecol 2005, 105:29-33.